e coli atcc 33876 Search Results


94
ATCC escherichia coli atcc 33876
Representation of antibacterial effect against certified strains of Staphylococcus aureus ATCC 25923 and <t>Escherichia</t> <t>coli</t> ATCC 33876: (a) MetOH, (b) AgNPs - FM, (c) FM and (d) EMT (5%).
Escherichia Coli Atcc 33876, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/escherichia coli atcc 33876/product/ATCC
Average 94 stars, based on 1 article reviews
escherichia coli atcc 33876 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

Image Search Results


Representation of antibacterial effect against certified strains of Staphylococcus aureus ATCC 25923 and Escherichia coli ATCC 33876: (a) MetOH, (b) AgNPs - FM, (c) FM and (d) EMT (5%).

Journal: F1000Research

Article Title: Plackett-Burman design in the biosynthesis of silver nanoparticles with Mutisia acuminatta (Chinchircoma) and preliminary evaluation of its antibacterial activity

doi: 10.12688/f1000research.140883.1

Figure Lengend Snippet: Representation of antibacterial effect against certified strains of Staphylococcus aureus ATCC 25923 and Escherichia coli ATCC 33876: (a) MetOH, (b) AgNPs - FM, (c) FM and (d) EMT (5%).

Article Snippet: The silver nanoparticles biosynthesized with the methanolic fraction (AgNPs-FM) showed enhanced antibacterial activity against certified bacteriological strains of Staphylococcus aureus ATCC 25923 and Escherichia coli ATCC 33876.

Techniques:

Agar well assays for the evaluation of antibacterial activity against Escherichia coli ATCC 33876: (A) EMT (5%), (B) FM, (C) AgNPs-FM and (D) Methanol (blank).

Journal: F1000Research

Article Title: Plackett-Burman design in the biosynthesis of silver nanoparticles with Mutisia acuminatta (Chinchircoma) and preliminary evaluation of its antibacterial activity

doi: 10.12688/f1000research.140883.1

Figure Lengend Snippet: Agar well assays for the evaluation of antibacterial activity against Escherichia coli ATCC 33876: (A) EMT (5%), (B) FM, (C) AgNPs-FM and (D) Methanol (blank).

Article Snippet: The silver nanoparticles biosynthesized with the methanolic fraction (AgNPs-FM) showed enhanced antibacterial activity against certified bacteriological strains of Staphylococcus aureus ATCC 25923 and Escherichia coli ATCC 33876.

Techniques: Activity Assay